Envoy Medical, Inc. (COCH)
Automate Your Wheel Strategy on COCH
With Tiblio's Option Bot, you can configure your own wheel strategy including COCH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol COCH
- Rev/Share 0.0099
- Book/Share -1.1359
- PB -1.2237
- Debt/Equity -0.0381
- CurrentRatio 1.0944
- ROIC -6.9767
- MktCap 29643974.0
- FreeCF/Share -0.7833
- PFCF -1.7746
- PE -1.5184
- Debt/Assets 0.0889
- DivYield 0
- ROE 1.0556
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Envoy Medical Achieves Clinical Trial Milestone and is Optimistic About Expansion into Final Stage of Trial
Published: May 13, 2025 by: Newsfile Corp
Sentiment: Neutral
White Bear Lake, Minnesota--(Newsfile Corp. - May 13, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices that leverage the ear's natural anatomy, today announces achieving the important milestone of successful activation of all 10 study participants' fully implanted Acclaim® cochlear implants in the first stage of the Company's pivotal clinical trial. Brent Lucas, CEO of Envoy Medical commented: "We are excited to report the positive and meaningful progress of our pivotal clinical trial, which is currently on track and moving along as anticipated.
Read More
EdgarAgents Debuts EA34 Plugin at Centri Capital Conference to Simplify and Expedite Financial Filing Process for Mid-to-Microcap Companies
Published: April 22, 2025 by: GlobeNewsWire
Sentiment: Neutral
EA34 Plugin eliminates complex tagging process for financial reporting teams and enables intuitive collaboration via familiar Microsoft 365® apps and services EA34 Plugin eliminates complex tagging process for financial reporting teams and enables intuitive collaboration via familiar Microsoft 365® apps and services
Read More
Envoy Medical Reports Fourth Quarter and Full Year 2024 Financial Results
Published: March 31, 2025 by: Newsfile Corp
Sentiment: Neutral
Company Provides Corporate Update that Includes Information on its Progress Enrolling Subjects in its Pivotal Clinical Study for Breakthrough Device, the Fully Implanted Acclaim® Cochlear Implant White Bear Lake, Minnesota--(Newsfile Corp. - March 31, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced its corporate and financial results for the fourth quarter and full year ended December 31, 2024, as well as other subsequent events. Brent Lucas, CEO of Envoy Medical commented: "Envoy Medical had a successful 2024 and we are off to a wonderful start in …
Read More
Hearing Device Coverage Clarification Act Reintroduced in House and Senate
Published: March 17, 2025 by: Newsfile Corp
Sentiment: Neutral
Seek to clarify that certain hearing implants are prosthetics and therefore not subject to the hearing aid coverage exclusion, allowing for potential Medicare coverage White Bear Lake, Minnesota--(Newsfile Corp. - March 17, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing systems, today announced the reintroduction of the Hearing Device Coverage Clarification Act in both the U.S. House of Representatives and U.S. Senate. Representative Michelle Fischbach (R-MN) reintroduced the House version of the bill - H.R.
Read More
Envoy Medical Secures $10 Million in Funding to Advance Pivotal Clinical Trial of Breakthrough Hearing Device
Published: March 12, 2025 by: Newsfile Corp
Sentiment: Neutral
Billionaire Entrepreneur Glen Taylor, the Company's Largest Shareholder, Continues to Invest Significant Capital into the Company Furthering Its Progress White Bear Lake, Minnesota--(Newsfile Corp. - March 12, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced securing $10 Million in financing from its largest existing shareholder, billionaire entrepreneur Glen Taylor. The financing provides the Company with access to additional capital during what it expects to be a transformative year with several important milestones.
Read More
Envoy Medical to Participate in the 37th Annual ROTH Conference
Published: March 10, 2025 by: Newsfile Corp
Sentiment: Neutral
White Bear Lake, Minnesota--(Newsfile Corp. - March 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices, today announced that it will participate in the 37th Annual ROTH Conference being held on March 16 - 18, 2025 at the Laguna Cliffs Marriott Resort and Spa in Dana Point, California. Brent Lucas, Chief Executive Officer, and David R.
Read More
About Envoy Medical, Inc. (COCH)
- IPO Date 2021-04-29
- Website https://www.envoymedical.com
- Industry Medical - Devices
- CEO Mr. Brent T. Lucas Esq.
- Employees 42